In the first small RCT, the Atomic-AHF omecamtiv mecarbil did not improve dyspnea, while the COSMIC-HF trial showed improvement of cardiac function, reduction of ventricular diameters, and of plasma NT-PRO BNP compared to placebo [34,35]. The gene discussed is NPPB; the disease is hydrops fetalis.